Idea management in support of pharmaceutical front end of innovation
by Annabeth Aagaard
International Journal of Technology, Policy and Management (IJTPM), Vol. 12, No. 4, 2012

Abstract: The pharmaceutical industry faces continuing pressures from rising R&D costs, depreciating value of patents and pressures from public authorities to cut healthcare costs. These challenges have increased the focus on shortening development times and the efficiency of Front-End of Innovation (FEI). This paper explores how idea management may be applied as a tool in facilitation of pharmaceutical FEI, which is studied through an exploratory case study of six medium to large pharmaceutical companies. The derived findings reveal several key similarities, which have implications for policy-makers and the way FEI should be supported in Pharma.

Online publication date: Wed, 31-Dec-2014

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Technology, Policy and Management (IJTPM):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com